View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 13, 2020

Sanofi commits 100 million doses of hydroxychloroquine

Sanofi has committed to donate 100 million doses of hydroxychloroquine across 50 countries to support fight against Covid-19.

The company increased its production capacity by 50% and is making preparations to further boost production over the coming months.

If ongoing clinical trials demonstrate hydroxychloroquine’s safety and efficacy in Covid-19, Sanofi will continue to donate the drug to governments and hospitals.

Sanofi CEO Paul Hudson said: “It is critical that international authorities, local governments, manufacturers, and all the other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it.

“If the trials prove positive, we hope our donation will play a critical role for patients.”

Meanwhile, the US National Institutes of Health started the ORCHID Study of hydroxychloroquine to treat adults hospitalised with Covid-19.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy